128 related articles for article (PubMed ID: 11731952)
1. Ischemic cardiovascular disease in persons with human immunodeficiency virus infection.
David MH; Hornung R; Fichtenbaum CJ
Clin Infect Dis; 2002 Jan; 34(1):98-102. PubMed ID: 11731952
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
[TBL] [Abstract][Full Text] [Related]
3. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.
Lichtenstein KA; Armon C; Buchacz K; Chmiel JS; Buckner K; Tedaldi EM; Wood K; Holmberg SD; Brooks JT;
Clin Infect Dis; 2010 Aug; 51(4):435-47. PubMed ID: 20597691
[TBL] [Abstract][Full Text] [Related]
4. [Spectrum of cardiovascular disease in HIV-infected patients].
Lozano F
Enferm Infecc Microbiol Clin; 2009 Sep; 27 Suppl 1():3-9. PubMed ID: 20172409
[TBL] [Abstract][Full Text] [Related]
5. Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients.
Iloeje UH; Yuan Y; L'italien G; Mauskopf J; Holmberg SD; Moorman AC; Wood KC; Moore RD
HIV Med; 2005 Jan; 6(1):37-44. PubMed ID: 15670251
[TBL] [Abstract][Full Text] [Related]
6. Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome.
Fichtenbaum CJ; Dunagan WC; Powderly WG
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):51-7. PubMed ID: 8548346
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
[TBL] [Abstract][Full Text] [Related]
8. Update on cardiovascular complications in HIV infection.
Currier JS
Top HIV Med; 2009; 17(3):98-103. PubMed ID: 19675367
[TBL] [Abstract][Full Text] [Related]
9. Is estimated cardiovascular risk higher in HIV-infected patients than in the general population?
De Socio GV; Martinelli L; Morosi S; Fiorio M; Roscini AR; Stagni G; Schillaci G
Scand J Infect Dis; 2007; 39(9):805-12. PubMed ID: 17701720
[TBL] [Abstract][Full Text] [Related]
10. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery disease and human immunodeficiency virus infection.
Passalaris JD; Sepkowitz KA; Glesby MJ
Clin Infect Dis; 2000 Sep; 31(3):787-97. PubMed ID: 11017831
[TBL] [Abstract][Full Text] [Related]
14. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
15. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
[TBL] [Abstract][Full Text] [Related]
16. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
Guo JJ; Jang R; Louder A; Cluxton RJ
Pharmacotherapy; 2005 Aug; 25(8):1044-54. PubMed ID: 16207094
[TBL] [Abstract][Full Text] [Related]
17. Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection.
Schillaci G; De Socio GV; Pirro M; Savarese G; Mannarino MR; Baldelli F; Stagni G; Mannarino E
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2381-5. PubMed ID: 16123321
[TBL] [Abstract][Full Text] [Related]
18. Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study.
De Socio GV; Parruti G; Quirino T; Ricci E; Schillaci G; Adriani B; Marconi P; Franzetti M; Martinelli C; Vichi F; Penco G; Sfara C; Madeddu G; Bonfanti P;
J Infect; 2008 Jul; 57(1):33-40. PubMed ID: 18436307
[TBL] [Abstract][Full Text] [Related]
19. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
20. CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
Hulgan T; Raffanti S; Kheshti A; Blackwell RB; Rebeiro PF; Barkanic G; Ritz B; Sterling TR
J Infect Dis; 2005 Sep; 192(6):950-7. PubMed ID: 16107946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]